Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2012

View Archived Issues

New strategy shows promise to eradicate latent HIV-1

ROCK inhibitor and calcium channel blocker show synergy in phase I trial

New PI3Kalpha and mTOR inhibitors designed in Spain

New antibacterial products presented

Aileron Therapeutics reports new candidate cancer therapies

Prostaglandin E2 derivative shows therapeutic potential in preclinical and clinical studies

New PARP-1 inhibitors synthesized in China

MediVector receives U.S. DOD contract to develop broad-spectrum influenza drug

SK Biopharmaceuticals launches phase II trial of constipation therapeutic

Genmab submits protocol amendment for phase III ofatumumab trial

Pharmaxis provides update on Bronchitol MAA

Medivir to file application for phase I trials of bone disorder candidate

NICE issues recommendation for dabigatran

Wintherix presents new activators of Wnt signaling

Novel somatostatin sst5 receptor antagonists developed

Novel E-NPP 2 inhibitors disclosed

Alcon and Astellas Pharma report new bradykinin receptor agonists

Boehringer Ingelheim Pharma designs new FLAP and leukotriene synthesis inhibitors

Novel hedgehog pathway activators divulged by Fate Therapeutics

FDA grants orphan drug status to verteporfin therapy

Telormedix completes safety portion of TMX-101 study

Galderma completes phase III studies of candidate for facial erythema of rosacea

Health Canada approves diclofenac therapy

TH-302 receives E.U. orphan drug status

Sodium channel blocker enters proof-of-concept trial

FDA proposes adjustment to risk classification of certain tuberculosis tests

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...